In fact, estrogen suppressed tumor growth functions by inhibiting the JAK1/STAT6 signaling pathway that drives macrophage M2 activation (Yan et al., 2012), potentially explaining predominance of HCC in men compared to women. Here, STAT6 is linked to hepatocellular carcinoma.